+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Psoriasis Drugs Market Research Reports

Moderate Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Moderate Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Chronic Plaque Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Plaque Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Liposomal Cyclosporine A Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Liposomal Cyclosporine A Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Plaque Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Plaque Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 240 Pages
  • Global
From
Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Coal Tar Topical Solution Market Outlook Report - Industry Size, Trends, Insights, Market Share, Competition, Opportunities, and Growth Forecasts by Segments, 2022 to 2030 - Product Thumbnail Image

Coal Tar Topical Solution Market Outlook Report - Industry Size, Trends, Insights, Market Share, Competition, Opportunities, and Growth Forecasts by Segments, 2022 to 2030

  • Report
  • September 2023
  • 146 Pages
  • Global
From
Generalized Pustular Psoriasis (GPP) - Competitive Landscape - Product Thumbnail Image

Generalized Pustular Psoriasis (GPP) - Competitive Landscape

  • Report
  • December 2023
  • 78 Pages
  • Global
From
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • November 2023
  • 1203 Pages
  • Global
From
Hydrocortisone-17-butyrate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Hydrocortisone-17-butyrate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 94 Pages
  • Global
From
Calcitriol Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Calcitriol Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • January 2024
  • 78 Pages
  • Global
From
Methotrexate (CAS 59-05-2) Global Market Research Report 2024 - Product Thumbnail Image

Methotrexate (CAS 59-05-2) Global Market Research Report 2024

  • Report
  • June 2024
  • 50 Pages
  • Global
From
Hydrocortisone (CAS 50-23-7) Global Market Research Report 2024 - Product Thumbnail Image

Hydrocortisone (CAS 50-23-7) Global Market Research Report 2024

  • Report
  • June 2024
  • 50 Pages
  • Global
From
US HUMIRA Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

US HUMIRA Market Size, Forecast, and Market Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • United States
Psoriasis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Psoriasis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
HUMIRA® (Adalimumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive/Terminated/Withdrawn Biosimilars, Industry/Non-Industry Partnerships - Product Thumbnail Image

HUMIRA® (Adalimumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive/Terminated/Withdrawn Biosimilars, Industry/Non-Industry Partnerships

  • Report
  • July 2021
  • Global
From
Ustekinumab (Stelara) Biosimilars Pipeline Review - Product Thumbnail Image

Ustekinumab (Stelara) Biosimilars Pipeline Review

  • Report
  • June 2024
  • Global
From
Adalimumab (Humira) Biosimilars Pipeline Review - Product Thumbnail Image

Adalimumab (Humira) Biosimilars Pipeline Review

  • Report
  • June 2024
  • Global
From
STELARA (Ustekinumab), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

STELARA (Ustekinumab), Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Psoriasis - Market Insights, Competitive Landscape and Market Forecast-2027 - Product Thumbnail Image

Psoriasis - Market Insights, Competitive Landscape and Market Forecast-2027

  • Report
  • July 2022
  • 100 Pages
  • Global
From
Loading Indicator

The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms. The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more